It is important to note that there is no established causal link in human studies between GLP-1 receptor activation and thermoregulation
Furthermore, cardiovascular results for oral semaglutide were similar to the results observed in the SUSTAIN-6 trial with injectable semaglutide, suggesting that the oral and SC formulations share similar cardiovascular safety profiles
How GLP-1 Medications Fit into Modern Obesity and Menopause Care GLP-1 receptor agonists, medications like Ozempic, Wegovy, and Mounjaro , were developed over two decades ago for type 2 diabetes
Another meta-analysis of 19 RCTs showed a reduced in-hospital mortality rate in vit-C supplemented COVID-19 patients (24.1%) compared to non-supplemented group (33.9%) 722
Possible effects include: Loose or excess skin Fatigue Hair thinning Muscle loss (if not strength training) Gallbladder issues with rapid loss Nutrient deficiencies if diet is poor Most risks are reduced with gradual weight loss, adequate protein, strength training, and medical supervision
